Biogen CFO Michael McDonnell to retire Feb 2025; Robin Kramer named successor

BIOGEN INC.

Michael McDonnell to retire as CFO effective February 28, 2025, after serving since August 2020.
Robin Kramer, current Chief Accounting Officer, appointed CFO effective upon McDonnell's retirement.
Kramer's base salary $750,000; target bonus 80% of base; 2025 target LTI grant $3.75 million.
Kramer joined Biogen in 2018, served as CAO since 2020, also leads Treasury, procurement, and global business services.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael McDonnell

Chief Financial Officer

BIIB · BIOGEN INC.

Effective: 2025-02-28
Successor: Robin Kramer
Filed: October 30, 2024, 7:59 PM ET

On October 28, 2024, Michael McDonnell, Chief Financial Officer of Biogen Inc. (the “Company”) notified the Company that he will retire from the Company effective February 28, 2025.

Appointed

Robin Kramer

Chief Financial Officer

BIIB · BIOGEN INC.

Effective: 2025-02-28
Filed: October 30, 2024, 7:59 PM ET

Robin Kramer, the Company’s Chief Accounting Officer and Head of Global Business Services and Treasury has been appointed Chief Financial Officer effective upon Mr. McDonnell’s retirement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael McDonnell departed as Chief Financial Officer at BIOGEN INC..

Action: retire
Role: Chief Financial Officer

Exact text from the filing

On October 28, 2024, Michael McDonnell, Chief Financial Officer of Biogen Inc. (the “Company”) notified the Company that he will retire from the Company effective February 28, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Robin Kramer was appointed as Chief Financial Officer at BIOGEN INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Robin Kramer, the Company’s Chief Accounting Officer and Head of Global Business Services and Treasury has been appointed Chief Financial Officer effective upon Mr. McDonnell’s retirement.

View on SEC.gov

BIOGEN INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-247628

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.